Beam Therapeutics BEAM
NASDAQ BEAM
$24.39 -0.06 (-0.25%)
At close: Oct 1, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Cash from Financing Activities (2019 - 2026)

Updated

Beam Therapeutics (BEAM) reported Cash from Financing Activities of $7.52 million for Q2 2026, up 578.4% from $1.11 million a year earlier but down 92.2% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Beam Therapeutics' Cash from Financing Activities came in at $107.69 million, down 77.5% year-over-year; for FY2025, it came in at $478.05 million.

  • Cash from Financing Activities has a five-year compound annual growth rate of 8.2% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $7.74 million in FY2024 (-97.2%), $276.45 million in FY2023 (+147.7%), $111.59 million in FY2022 (-85.2%) and $756.14 million in FY2021 (+134.6%).
  • Five-year quarterly Cash from Financing Activities spans a low of $133,000 in Q2 2024 and a high of $473.38 million in Q1 2025.
  • Year over year, Cash from Financing Activities gained in three of the last seven quarters, with growth averaging 147.7%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q2 2025 (growth of 733.8%); the low point was Q2 2024 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $96.61 million (Q1 2026), $1.89 million (Q4 2025) and $1.68 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Beam Therapeutics 2.52 Bn 2.52 Bn - 7.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.52 Mn
Mar 31, 2026 96.61 Mn
Dec 31, 2025 1.89 Mn
Sep 30, 2025 1.68 Mn
Jun 30, 2025 1.11 Mn
Mar 31, 2025 473.38 Mn
Dec 31, 2024 3.44 Mn
Sep 30, 2024 1.26 Mn
Jun 30, 2024 133,000.00
Mar 31, 2024 2.90 Mn
Dec 31, 2023 33.71 Mn
Sep 30, 2023 36.78 Mn
Jun 30, 2023 107.54 Mn
Mar 31, 2023 98.42 Mn
Dec 31, 2022 32.01 Mn
Sep 30, 2022 1.56 Mn
Jun 30, 2022 22.34 Mn
Mar 31, 2022 55.68 Mn
Dec 31, 2021 21.54 Mn
Sep 30, 2021 320.89 Mn
API Access

Beam Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BEAM&period=max&api_key=YOUR_API_KEY